|
 |
XalatanThis page contains recent news articles, when available, and an overview of Xalatan but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.A study reported in the American Journal of Ophthalmology showed the yearly cost in 2006 for a patient on three brand-name eyedrops (Xalatan, Alphagan P and ... Modesto Bee Lashing out at Latisse® - Nov 3, 2009 Bimatoprost (Lumigan®) and latanoprost (Xalatan®) are members of the prostamide class of drugs that can manage some forms of glaucoma by reducing ... ScienceBlogs (blog) Lumigan X EU Committee Recomendation - Oct 28, 2009 Travatan-Z has captured market share from both cannabilization of Travatan and prescriber replacement of Lumigan and Xalatan, the main competition in the ... Gerson Lehrman Group Aerie Pharmaceuticals` ROCK Inhibitor, AR-12286, Demonstrates Positive Results ... - Oct 22, 2009 AR-12286 may have broad implications in glaucoma therapy and could offer the next major advancement in the field since the approval of latanoprost (Xalatan) ... Reuters REG-Pfizer Inc Pfizer Reports Third-Quarter 2009 Results - Oct 20, 2009 Examples of products in this business unit include, but are not limited to, Xalatan, Zyvox, Geodon and Genotropin. All revenues for such products are ... Reuters Report of NicOx's financial results for the first three quarters of 2009 - Oct 21, 2009 As part of this agreement, Pfizer also granted NicOx the right to access and use certain proprietary Xalatan® (latanoprost) data. NicOx also regained rights ... SYS-CON Media (press release) NicOx : recule de 3,2% - Oct 22, 2009 ..."Dans le cadre de cet accord, Pfizer a également accordé à NicOx le droit d'accéder à certaines données du Xalatan (latanoprost) lui appartenant et de les ... Boursier.com MARIJUANA AS MEDICINE: Legal process requires paperwork ... - 30 Aug 2009 Wellish said laser treatment and the eyedrops Xalatan, Lumigan and Travatan are much more effective for glaucoma. "For marijuana to work, the patient would Las Vegas Review - Journal France's NicOx to buy back eye drug rights from Pfizer - Aug 6, 2009 ...two mid-stage tests in patients with primary open-angle glaucoma and ocular hypertension, NicOx has won access to data on Pfizer's eye drug Xalatan. Reuters Pfizer makes push in ophthalmic market with restructuring, R&D ... - Aug 25, 2009 Despite speculation that Pfizer might discontinue its ophthalmology activity after the glaucoma drug Xalatan (latanoprost ophthalmic solution) loses US OSN SuperSite NicOx terminates agreement with Pfizer for nitric oxide-donating ... - Aug 10, 2009 As part of this agreement, Pfizer has granted NicOx the right to access and use certain proprietary Xalatan(R) (latanoprost) data. Trading Markets (press release) BUYINS.NET: GE, RF, WFC, F, PFE, LVS With Highest Daily Short ... - Aug 28, 2009 Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. Trading Markets (press release) DotW: Cash for Clunkers - Aug 7, 2009 Pfizer's Xalatan, which racked up $1.7 billion in worldwide sales in 2008, goes generic in 2011, so future glaucoma products like '207 will have to do The IN VIVO Blog Pfizer to Lift Payout? - Aug 16, 2009 Also expected to go off patent in the next four years are its Viagra treatment for erectile dysfunction ($1.9 billion), Xalatan for glaucoma ($1.7 billion) Barron's Going, going, gone Patents set to expire soon on many brand-name drugs - Aug 7, 2009 Off patent in 2011: Advair, Plavix, Zyprexa, Effexor XR, Aprovel, Xalatan, Astelin, Synarel, Actos, Follistim, Viramune. Off patent in 2012: Crestor, Modern Medicine 06/08/09 07:00 NicOx réacquiert les droits du PF 03187207 pour le ... - Aug 5, 2009 Dans le cadre de cet accord, Pfizer a accordé à NicOx le droit d'accéder à certaines données du Xalatan® (latanoprost) lui appartenant et de les utiliser. TF1 ACCORD AVEC PFIZER INC POUR LE GLAUCOME - Aug 5, 2009 Dans le cadre de ce contrat, NicOx peut également accéder à certaines données du Xalatan, appartenant à Pfizer Inc. Investir.fr NicOx : accord sur un traitement avec Pfizer - Aug 5, 2009 Dans le cadre de cet accord, Pfizer a accordé à NicOx le droit d'accéder à certaines données du Xalatan (latanoprost) lui appartenant et de les utiliser. Boursorama Marchés / bilan hebdomadaire : le CAC40 gagne encore 2,7% - Aug 7, 2009 Dans le cadre de cet accord, Pfizer a accordé à NicOx le droit d'accéder à certaines données du Xalatan (latanoprost) lui appartenant et de les utiliser, Boursier.com Study: Company sponsorship of glaucoma drug trials did not affect ... - Jul 10, 2009 Dr. Buys and colleagues examined 473 prostaglandin studies of Xalatan (latanoprost 0.005%, Pfizer), Lumigan (bimatoprost 0.03%, Allergan) and Travatan OSN SuperSite Strange Side Effects - Jul 9, 2009 The glaucoma drops Xalatan can turn blue eyes into brown, and the common heart medicine amiodarone can turn your skin gray-blue, especially if you get too News4Jax.com Brooke Astor Supported Her Son, The Pharmaceutical Industry - Jun 30, 2009 ...including the medications Bextra, Tenormin, Prevacid, Alphagan, Sonata, Neurontin, Zoloft, Aricept, Detrol, Rhinocort, Xalatan, Antivert, Percocet, Cityfile Researcher who shed light on glaucoma dies at 55 - Apr 19, 2009 Camras helped develop latanoprost, sold under the trade name Xalatan, which has been the most effective drug to treat glaucoma. Camras joined UNMC's staff Long Beach Press-Telegram Deaths elsewhere - Apr 19, 2009 Camras, 55, helped develop latanoprost, sold under the trade name Xalatan, the most effective drug to treat glaucoma. He died of heart failure Tuesday in Detroit Free Press Eye-Opening Facts About Glaucoma - Apr 1, 2009 Latanoprost ophthalmic solution, also known as Xalatan®, and other treatments can help people with glaucoma preserve their vision, but only if patients North American Press Syndicate 畅销è?¯ä¸“利纷纷到期 å“?牌è?¯åŽ‚怎么办？ - Apr 9, 2009 ...而除了立普妥，从现在到2012年底，辉瑞还将失去Caduetã€?Geodonã€?Viagra（万艾å?¯ï¼‰å’ŒXalatanç‰äº§å“?的专利ä¿?护。辉瑞所有å?—专利过期影å“?的产å“?åŠ åœ¨ä¸€èµ·ï¼Œå¤§çº¦æœ‰180亿美元 人民网 Pfizer, Bausch team up to promote eye drugs - Mar 3, 2009 The five-year agreement involves Pfizer's glaucoma drug Xalatan and three Bausch products: Alrex for conjunctivitis, Lotemax for inflammatory conditions, Reuters Eye drug boost - Mar 12, 2009 The five-year agreement involves Pfizer's glaucoma drug Xalatan and three B&L products: Alrex for conjunctivitis, Lotemax for inflammatory conditions and Optician Online Financial results for full year 2008: NicOx in a unique position ... - Feb 25, 2009 Two phase 2 studies for PF-03187207 in glaucoma patients conducted by Pfizer Inc demonstrated an improvement over Xalatan(R) 0.005%, in terms of intraocular FOXBusiness 'The sneak thief of sight' is easily treatable if caught early - Mar 9, 2009 ..."Common medications to lower eye pressure are Xalatan and Travatan." Gordon stresses the importance of taking the drops exactly as instructed. Ottawa Citizen About this author: - Mar 9, 2009 Besides Lipitor, Pfizer will also lose patent protection on Caduet, Geodon, Viagra, and Xalatan between now and the end of 2012. Seeking Alpha Ask the Pharmacist: Treatment options for glaucoma - Mar 4, 2009 This is why Xalatan, Lumigan and Travatan are so popular. They relax muscles in your eyes so fluid can naturally drain, taking off the pressure. Sun-Sentinel.com Pfizer makes small deals, too - Mar 3, 2009 ...in the US Pfizer and Bausch will each market both companies' products, which include Pfizer's Xalatan and Bausch & Lomb's Altrex, Lotemax and Zylet. FiercePharma Business briefs - Mar 4, 2009 B&L said it signed a five-year agreement with Pfizer Inc. in which the companies will co-promote each other's ophthalmic pharmaceuticals, including Xalatan, Rochester Democrat and Chronicle BUYINS.NET: Market Maker Surveillance Report. Top 6 Highest Net ... - Mar 11, 2009 Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. TMC Net Pfizer et Bausch & Lomb vont co-promouvoir des produits ... - Mar 3, 2009 ...porte sur le médicament anti-glaucome Xalatan de Pfizer, ainsi que sur trois produits de Bausch & Lomb contre les allergies ou inflammations oculaires, Romandie.com 辉瑞与å?šå£«ä¼¦è?”手共å?Œé”€å”®æ²»ç–—眼病处方è?¯ - Mar 3, 2009 ...两家公å?¸æ¤æ¬¡ç¾ç½²çš„å??议为期5年，其ä¸æ¶‰å?Šè¾‰ç‘žçš„é?’光眼治疗è?¯ç‰©Xalatan，以å?Šå?šå£«ä¼¦çš„三个产å“?：结膜炎治疗è?¯ç‰©Alrex，眼部炎症治疗è?¯ç‰©Lotemax，以å?ŠæŠ—看抗感染 科讯网 í™”ì?´ìž?, 바슈&롬과 안과약품 ê³µë?™íŒ?ì´‰ 하기로 - Mar 3, 2009 ...그러나 ì?´ë²ˆ 계약ì—? í™”ì?´ìž?ì?˜ 안약 ‘잘ë?¼íƒ„(Xalatan)'ê³¼ 바슈&롬사ì?˜ â€™ì•Œë ‰ìŠ¤(Alrex)'등ì?´ í?¬í•¨ë?œ 것으로 ì•Œë ¤ì¡Œë‹¤. 한편 í™”ì?´ìž?는 ì?´ë²ˆ í˜‘ë ¥ê´€ê³„ì™€ ìƒ?관없ì?´ 현재 메디게이트뉴스 Tanie leki dla chorych przewlekle. DziÅ› cz.2 - Mar 16, 2009 Za xalatan pacjent zapÅ‚aci 15,38 zÅ‚, a nie jak do tej pory 94 zÅ‚. ZaoszczÄ™dzÄ… też chorzy na cukrzycÄ™ i astmÄ™. Refundowane bÄ™dÄ… również specyfiki stosowane w Kurier Lubelski Résultats financiers pour l'année 2008 : NicOx dans une situation ... - Feb 25, 2009 Ces résultats ont démontré une amélioration par rapport au Xalatan® 0005% qui ne s'est pas révélée statistiquement significative sur le critère d'évaluation Le Revenu Pfizer con Wyeth mil mdd de ventas aquÃ, crisis más oportunidades ... - Feb 20, 2009 Los más rentables son Lipitor para el colesterol, Lyrica, Celebrex, Norvasc, Viagra, Xalatan, Detrol, por mencionar algunos. Milenio í™”ì?´ìž?, 본격 다ê°?í™”-ì œë„¤ë¦Â·ì•ˆê³¼ 확장 - Mar 3, 2009 ...ì?´ì—? 양사는 í™”ì?´ìž?ì?˜ '잘ë?¼íƒ„'(Xalatan, latanoprost) ë°? 바슈롬ì?˜ 'ì•Œë ‰ìŠ¤'(Alrex, loteprednol), '로트맥스'(Lotemax, loteprednol), 'ì§ˆë ˆíŠ¸'(Zylet, 디지틀보사 Pfizer: accord avec le groupe Bausch & Lomb. - Mar 3, 2009 Le contrat est conclu sur une durée de 5 années et concerne le traitement Pfizer's Xalatan et Bausch & Lomb's Alrex, Lotemax et Zylet. BFM radio Pfizer’s $166.6 Billion Troubled Merger History - Jan 23, 2009 Pfizer faces the lapse of exclusivity agreements on its most-successful drugs: Lipitor, Caduet, Vfend, and Xalatan in 2011; Geodon, Viagra, and Detrol/LA in Wall Street Journal Blogs, A look at drugmakers Pfizer and Wyeth - Jan 23, 2009 ...$1.7B Xalatan, glaucoma, $1.8B Zosyn, antibiotic, $1.3B Detrol, bladder trouble, $1.2B Premarin, menopause, $1.1B Sources: Companies, analyst reports. The Associated Press For Pfizer, a Big Buy Could Be a Big Mistake - Jan 15, 2009 Pfizer's glaucoma drugs Xalatan and Xalacom produced $1.29 billion for the same period. Ophthalmology is one of Pfizer's top 10 research areas, Motley Fool Pfizer Reports Fourth-Quarter and Full-Year 2008 Results and 2009 ... - Jan 26, 2009 123 114 9 39 35 11 84 79 8 - OPHTHALMOLOGY 461 464 (1) 144 141 2 317 323 (2) XALATAN / XALACOM 454 453 - 144 141 2 310 312 (1) - ENDOCRINE DISORDERS 296 MarketWatch (press release) BUYINS.NET: Market Maker Surveillance Report. Highest Net Sell ... - Jan 27, 2009 Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; Trading Markets (press release), Pfizer Eyes Wyeth. We Ask "Why?" - Jan 23, 2009 ...cholesterol drug Lipitor, pain drug Celebrex, fibromyalgia drug Lyrica, erectile dysfunction drug Viagra, glaucoma drug Xalatan, and cancer drug Sutent. Zacks.com, Pillen-Milliardendeal: Pfizer schluckt Wyeth - Jan 26, 2009 ...hätte sich wegen des Auslaufens von Patenten (16,7 Mrd. Dollar mit Lipitor, Viagra, dem Blutdruckmittel Norvasc und dem Augenmittel Xalatan) mit dem 6. Tirol Online, Letter: Wide prescription choice requires intelligent study - Nov 30, 2008 However, many drugs in this tier have a full price that is less than $95, such as Hyzaar, $87; Fosamax, $78; Xalatan, $69; and Toprol XL, $29. TCPalm, Annotations for Trinity issue #27 - Dec 4, 2008 Xalatan is a brand name prescription eyedrop. Xalitan’s eyes are so red he could probably go for some eyedrops. Xalitan Xor is a pretty cool name - suitably Comic Book Resources, Martin Mackay - President, Pfizer Global Research & Development - 21 Oct 2008 We continue to see steady growth in several key products, including Lyrica, Celebrex, Viagra, Sutent, Xalatan, Zyvox and Geodon. We're pleased of the solid Seeking Alpha, Examine the Pfizer - Market Outlook for a Global Leader, 2008-2013 - Oct 6, 2008 Strong Competition in the Erectile Dysfunction Market 4.8 Xalatan/Xalacom Revenues Look Promising Until 2011 4.8.1 Xalatan/Xalacom Leads the Intraocular MarketWatch Glaucoma and vision 2020 - Oct 15, 2008 Prostaglandins like latanoprost (Xalatan), bimatoprost (Lumigan) and travoprost (Travatan). These are hormone-like substances which keep blood vessels Jamaica Gleaner, New Pfizer Incubator Chief Looks Far and Wide for New Science, Yet ... - Oct 14, 2008 It’s well chronicled that Pfizer faces patent expirations on blockbuster drugs such as Lipitor, Xalatan, and Viagra over the next five years. Xconomy, NicOx provides update on PF-03187207 and the ongoing research ... - Aug 24, 2008 The study was designed to compare the safety and efficacy of several doses of PF-03187207 to Xalatan(R) (latanoprost) and enrolled 112 Japanese patients MarketWatch Pfizer pulls plug on NiCox glaucoma drug in Asia - Aug 26, 2008 That trial compared the safety and efficacy of various doses of PF-03187207, a nitric oxide-donating prostaglandin analogue, to Pfizer’s own Xalatan Pharma Times (subscription), Pfizer, NicOx Eye Treatment Trial Falls Short - Aug 28, 2008 The study compared the safety and efficacy of several doses of the drug with Xalatan (latanoprost) in 112 Japanese patients. At day 28 of the study, Pharmaceutical Online (press release), Medicare's Poison Pill - Sep 3, 2008 In addition, I take two kinds of expensive eye-drops for glaucoma, Cosopt and Xalatan. Without this cocktail, I would be blind and at an increased risk of Mother Jones, NicOx donne un état des lieux sur le PF-03187207 et sur les ... - Aug 24, 2008 L'étude a été conçue pour comparer la sécurité d'emploi et l'efficacité de plusieurs dosages de PF‑03187207 par rapport au Xalatan® (latanoprost). Le Revenu, Le PF 03187207 n'est pas un produit mort - Aug 29, 2008 Nous avons trouvé un intérêt scientifique et commercial sur la molécule et certains avantages par rapport au Xalatan (ndlr : produit de Pfizer qui tombera Boursier.com, Nicox: état des lieux sur un traitement du glaucome. - Aug 24, 2008 L'étude a été conçue pour comparer la sécurité d'emploi et l'efficacité de plusieurs dosages de PF 03187207 par rapport au Xalatan (latanoprost). Boursorama, |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
